<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="134647">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02121379</url>
  </required_header>
  <id_info>
    <org_study_id>H-1401-116-549</org_study_id>
    <nct_id>NCT02121379</nct_id>
  </id_info>
  <brief_title>Randomized Clinical Trial of 8 Weeks Pulmonary Rehabilitation in Advanced Stage Lung Cancer Patients With COPD During Cytotoxic Chemotherapy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>Korea: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pulmonary rehabilitation might be benificial in advanced lung cancer patients with COPD who
      undergo cytotoxic chemotherapy.

      We will compare two groups, 8 week pulmonary rehabilitation group and usual care group.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>difference of VO2 max</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>difference maximal oxygen consumption during exercise cardiopulmonary test between before and after intervention/control</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>difference of  Saint George's Respiratory Questionannaire (SGRQ) score</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>the difference of SGRQ score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>difference of pulmonary function test</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>the difference of FVC and FEV1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>difference of 6 min walk test</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>the difference of 6 minute walk test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>difference of depression test</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>using Hospital Anxiety and Depression scale (HADS), measure the difference HADS between before and after intervention/control</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>COPD</condition>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>stretching exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pulmonary rehablitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>warming up exercise strengthening exercise aerobic exercise cool down</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>pulmonary rehabilitation</intervention_name>
    <arm_group_label>pulmonary rehablitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pathologically proven lung cancer

          -  chronic obstructive pulmonary disease

          -  age &gt; 20

          -  ECOG 0-1

          -  cytotoxic chemotherapy

        Exclusion Criteria:

          -  other history of cancer within 5 years

          -  other major disease associated with heart, lung, neurology, mental and metabolic
             disorders

          -  osteolytic bone metastatis to weight bearing site

          -  uncontrolled infection
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Young Sik Park, Dr</last_name>
    <phone>82-2-2072-7214</phone>
    <email>mdyspark@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Sik Park, Dr</last_name>
      <phone>82-2-2072-7214</phone>
      <email>mdyspark@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 30, 2014</lastchanged_date>
  <firstreceived_date>April 18, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Young Sik Park</investigator_full_name>
    <investigator_title>Assitant Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
